RE:RE:8.8 millReads to me like the loss was caused by terminating contracts and share based payouts. So we are making money outside of one offs and growing pains. What will be critically important is continued revenue growth which to me is to be expected. I was disappointed by the lack of clarity on white labelling progress, some LPs we are partnered with have in house capabilities or like Organigram signed with other producers which I haven’t decided yet is concerning or not. No mention of Valens Farms or product processed to date which kinda sucks. Hopefully we can see another 100% increase in revenues q3 over q2.